Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: Treatment of Portal Vein Tumor Thrombus After Hepatocellular Carcinoma Resection [NA]
ClinicalTrials.gov entry reports the completion of a study evaluating treatment of portal vein tumor thrombus after hepatectomy for hepatoce…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: the Efficacy and Safety of Ginsenoside Rg3 Capsule in Prevention of Postoperative Recurrence of Hepatocellular Carcinoma [NA]
A completed clinical trial evaluated the efficacy and safety of Ginsenoside Rg3 Capsule in preventing postoperative recurrence of hepatocell…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: The Influence of Resection Margin on the Recurrence of Early-stage Hepatocellular Carcinoma [NA]
This clinical trial update examines whether the width of the surgical resection margin affects recurrence risk in early-stage Hepatocellular…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence [NA]
A completed clinical trial evaluating intraoperative chemotherapy to prevent recurrence of hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC [Phase 1]
A Phase 1 study assessing adjuvant rapamycin to prevent recurrence after treatment of early-stage hepatocellular carcinoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH [Phase 1]
Phase 1 study evaluating an anti-recurrence therapy for hepatocellular carcinoma in patients with microvascular invasion and ASPH overexpres…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Postoperative Adjuvant TACE Treatment in CK18 Positive Patients
A completed trial evaluating postoperative adjuvant transarterial chemoembolization in CK18-positive hepatocellular carcinoma patients.
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Targeted Internal Radiation Therapy in Advanced HCC Patients. [NA]
A clinical trial evaluating targeted internal radiation therapy for hepatocellular carcinoma has completed. The study was sponsored by Easte…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Preoperative Pain Control in Liver Surgery Patients [NA]
The clinical trial evaluating preoperative pain control in liver surgery patients has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma [NA]
Clinical trial studying Yttrium-90 radioembolization for intermediate and advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC) [NA]
A completed clinical trial evaluating ulinastatin to prevent postoperative hepatic failure in hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1 [NA]
A clinical trial evaluating Rg3 in combination with transarterial chemoembolization for hepatocellular carcinoma with high Notch1 expression…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus [NA]
This entry notes the completion of a clinical trial evaluating laser ablation for intermediate and advanced hepatocellular carcinoma with po…
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma [NA]
Clinical trial comparing transarterial chemoembolization (TACE) plus sorafenib versus TACE alone for advanced hepatocellular carcinoma; phas…
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: A Study of GPC3 Redirected Autologous T Cells for Advanced HCC [Phase 1, Phase 2]
Phase 1/2 clinical study of GPC3-targeted autologous CAR-T cells for advanced hepatocellular carcinoma is underway. The snippet provides spo…
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma [Phase 1]
A Phase I clinical study of a new oral pentamidine formulation in hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation [Phase 1]
Phase 1 safety study of liver natural killer (NK) cell therapy in patients undergoing liver transplantation for hepatocellular carcinoma; re…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study [Phase 2, Phase 3]
Apatinib is being studied in combination with transarterial chemoembolization (TACE) for hepatocellular carcinoma with pulmonary metastasis,…
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer [Phase 1]
A Phase 1 study evaluating ADI-PEG 20 in combination with sorafenib for hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer [Phase 2]
Phase 2 trial evaluating Bevacizumab for unresectable nonmetastatic hepatocellular carcinoma has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a nano drug interventional therapy guided by digital subtraction angiography for hepatocellular carcin…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Cancer [Phase 1, Phase 2]
This entry reports the completion of a Phase 1/Phase 2 clinical trial evaluating HepaSphere interventional therapy using DSA for hepatocellu…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver [Phase 2]
A Phase II study of arsenic trioxide (Trisenox) for advanced hepatocellular carcinoma was terminated, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Sorafenib in Hepatocellular Carcinoma Clinical Practice in Italy
Clinical trial NCT01539681, conducted in Italy, evaluating sorafenib for hepatocellular carcinoma, has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas [Phase 2]
A Phase 2 trial evaluating the combination of erlotinib and docetaxel in advanced hepatocellular carcinoma and biliary tract carcinomas was …